MAP
BIOA

Moody Aldrich Partners’s BioAge Labs BIOA Stock Holding History

Moody Aldrich Partners’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Buy
+47,491
New +$858K 0.21% 114

Other funds holding BIOA

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TM
Torren Management San Diego, California $197M AUM
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Moody Aldrich Partners's BIOA Position: Q2 2026 in Review

Moody Aldrich Partners opened a new position in BioAge Labs (BIOA) in Q2 2026: 47,491 shares worth $1.16M. The stake represents 0.21% of the portfolio and ranks #114 among its holdings.

7 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Moody Aldrich Partners held 47,491 shares of BioAge Labs worth $1.16M as of Q2 2026.
  • BioAge Labs was a new Moody Aldrich Partners position in Q2 2026.
  • BioAge Labs made up 0.21% of Moody Aldrich Partners's portfolio in Q2 2026, its #114 holding.
  • 7 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Moody Aldrich Partners's 13F filing for Q2 2026, filed 15 Jul 2026.